Machine Learning Approaches for Predicting Alzheimer’s Disease Progression from Clinical Data

Abstract

Alzheimer's disease is a progressive neurodegenerative disorder that poses significant clinical, social, and economic challenges due to its gradual deterioration of cognitive functions, memory, reasoning ability, and daily living skills. Early identification of disease progression remains a major challenge because conventional diagnostic approaches often rely on periodic clinical assessments that may not adequately capture subtle changes occurring during the early stages of cognitive decline. The increasing availability of electronic health records, neuropsychological assessments, laboratory investigations, demographic information, genetic profiles, and neuroimaging-derived clinical parameters has created new opportunities for applying machine learning techniques to improve predictive accuracy and support personalized clinical decision-making. This study investigates the effectiveness of machine learning approaches for predicting Alzheimer's disease progression using multidimensional clinical data obtained from diverse patient populations. The research evaluates the capability of supervised learning algorithms, ensemble learning methods, support vector machines, decision trees, random forests, gradient boosting techniques, and deep neural networks to identify complex relationships among clinical variables associated with disease progression. The proposed predictive framework integrates comprehensive data preprocessing, feature selection, missing-value management, model optimization, and performance validation to improve the reliability and interpretability of clinical predictions. Particular attention is given to the contribution of demographic characteristics, cognitive assessment scores, neurological examinations, genetic risk indicators, laboratory biomarkers, medical history, and longitudinal clinical observations in enhancing prediction accuracy. The study further examines the importance of explainable machine learning models that enable clinicians to understand the contribution of individual clinical variables while maintaining transparency and confidence in algorithm-assisted decision-making. The findings indicate that machine learning models trained on carefully curated clinical datasets demonstrate superior predictive capability compared with conventional statistical approaches, enabling earlier identification of individuals at increased risk of rapid cognitive decline and disease progression. Furthermore, the integration of intelligent predictive analytics into clinical workflows has the potential to improve patient stratification, optimize treatment planning, facilitate timely therapeutic interventions, and support individualized patient monitoring. Despite these advantages, challenges associated with heterogeneous clinical datasets, missing information, class imbalance, model generalizability, ethical governance, patient privacy, and regulatory compliance remain important considerations for practical implementation. Overall, the study concludes that machine learning represents a valuable computational approach for advancing predictive neurology by transforming complex clinical data into meaningful prognostic insights, thereby supporting earlier intervention, improving healthcare decision-making, and contributing to the development of precision medicine strategies for Alzheimer's disease management.